Giuseppe Bianchi

Q: What Schools Are Affiliated With Giuseppe Bianchi

Giuseppe Bianchi is affiliated with the following schools: University of Milan, Weizmann Institute of Science, University of Oxford, Vita-Salute San Raffaele University, Stanford University, University of Sassari, University of Turin, Maastricht University, Karolinska Institute

Giuseppe Bianchi's AcademicInfluence.com Rankings

Giuseppe Bianchi

Computer Science

#7998

World Rank

#8416

Historical Rank

Machine Learning

#3151

World Rank

#3190

Historical Rank

Artificial Intelligence

#3452

World Rank

#3502

Historical Rank

Database

#5047

World Rank

#5244

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Giuseppe Bianchi's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Giuseppe Bianchi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giuseppe Bianchi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension (1997) (507)
Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. (1974) (346)
Two point mutations within the adducin genes are involved in blood pressure variation. (1994) (295)
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. (2002) (287)
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. (1996) (267)
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population (2001) (237)
Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. (1997) (223)
Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. (1986) (178)
Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. (1999) (177)
ACE and &agr;-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy (2003) (166)
Sodium pump α2 subunits control myogenic tone and blood pressure in mice (2005) (160)
Genome Sequencing Reveals Loci under Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat (2013) (159)
Effect in the conscious dog of constriction of the renal artery to a sole remaining kidney on haemodynamics, sodium balance, body fluid volumes, plasma renin concentration and pressor responsiveness to angiotensin. (1970) (158)
Association of the α-Adducin Locus With Essential Hypertension (1995) (157)
Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. (2002) (154)
The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. (1999) (151)
Organ Hypertrophic Signaling within Caveolae Membrane Subdomains Triggered by Ouabain and Antagonized by PST 2238* (2004) (148)
Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin, Part 2: Clinical Studies (2010) (145)
Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. (2006) (144)
Changes in Renin, Water Balance, and Sodium Balance During Development of High Blood Pressure in Genetically Hypertensive Rats (1975) (142)
Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. (1996) (142)
CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity. (2000) (138)
α-Adducin polymorphisms and renal sodium handling in essential hypertensive patients (1998) (137)
Essential hypertension (2003) (133)
Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. (1999) (132)
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. (2007) (129)
Adducin Polymorphism: Detection and Impact on Hypertension and Related Disorders (2005) (124)
Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. (1997) (123)
Evidence for an interaction between adducin and Na+-K+-ATPase: relation to genetic hypertension. (1999) (122)
A RENAL ABNORMALITY AS A POSSIBLE CAUSE OF "ESSENTIAL" HYPERTENSION (1979) (122)
Morphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local action. (1980) (115)
Plasma Ouabain-Like Factor During Acute and Chronic Changes in Sodium Balance in Essential Hypertension (2001) (108)
Red blood cell abnormalities and spontaneous hypertension in the rat. A genetically determined link. (1985) (102)
Hypertension-Linked Mutation in the Adducin &agr;-Subunit Leads to Higher AP2-&mgr;2 Phosphorylation and Impaired Na+,K+-ATPase Trafficking in Response to GPCR Signals and Intracellular Sodium (2004) (102)
Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. (2006) (101)
Endogenous ouabain in cardiovascular function and disease (2009) (100)
Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. (2005) (97)
PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. (1998) (97)
Carotid and Femoral Artery Stiffness in Relation to Three Candidate Genes in a White Population (2001) (97)
Hypertension in man with a kidney transplant: role of familial versus other factors. (1985) (97)
Renal Na,K-ATPase in genetic hypertension. (1996) (95)
Physiological Interaction Between &agr;-Adducin and WNK1-NEDD4L Pathways on Sodium-Related Blood Pressure Regulation (2008) (94)
Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. (2000) (93)
The hypertensive role of the kidney in spontaneously hypertensive rats. (1973) (92)
MECHANISM OF RENAL HYPERTENSION (1976) (92)
Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity. (1982) (90)
The development of a new strain of spontaneously hypertensive rats. (1974) (89)
Familial aggregation of cation transport abnormalities and essential hypertension. (1981) (84)
Age-dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain. (1986) (82)
Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa. (1993) (77)
Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients (1997) (77)
Genetics of essential hypertension: from families to genes. (2002) (75)
Left Ventricular Mass in Relation to Genetic Variation in Angiotensin II Receptors, Renin System Genes, and Sodium Excretion (2004) (73)
Pathogenesis of arterial hypertension after the constriction of the renal artery leaving the opposite kidney intact both in the anaesthetized and in the conscious dog. (1972) (73)
Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension. (2007) (72)
PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. (1999) (71)
Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. (1998) (69)
&agr;-Adducin 460Trp Allele Is Associated With Erythrocyte Na Transport Rate in North Sardinian Primary Hypertensives (2002) (68)
Association between hypertension and variation in the α- and β-adducin genes in a white population (2002) (67)
Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut. (1983) (67)
Carotid and femoral intima–media thickness in relation to three candidate genes in a Caucasian population (2002) (66)
Angiotensin-Converting Enzyme I/D and &agr;-Adducin Gly460Trp Polymorphisms: From Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome (2007) (65)
Benzodiazepine receptors and diazepam binding inhibitor: A possible link between stress, anxiety and the immune system (1993) (64)
The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP). (1988) (64)
Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure. (2007) (63)
Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. (2004) (63)
Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms. (2005) (63)
Ouabainlike factor in Milan hypertensive rats. (1992) (63)
beta-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations. (2003) (60)
Blockade of alpha 2-adrenoceptors by 1-(2-pyrimidinyl)-piperazine (PmP) in vivo and its relation to the activity of buspirone. (1988) (60)
Role of the adducin family genes in human essential hypertension (2005) (60)
Pharmacological Profile of the Novel Inotropic Agent (E,Z)-3-((2-Aminoethoxy)imino)androstane-6,17-dione Hydrochloride (PST2744) (2002) (59)
Salt, endogenous ouabain and blood pressure interactions in the general population (2003) (58)
Blood Pressure and Plasma Angiotensin II Concentration after Renal Artery Constriction and Angiotensin Infusion in the Dog: [5‐Isoleucine]angiotensin II and Its Breakdown Fragments in Dog Blood (1976) (58)
Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition (2013) (58)
Renal function in relation to three candidate genes. (2001) (58)
Renal dysfunction as a possible cause of essential hypertension in predisposed subjects. (1983) (56)
Renal micropuncture study of normotensive and Milan hypertensive rats before and after development of hypertension. (1978) (56)
alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. (2008) (55)
Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. (2006) (52)
Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy (2006) (51)
Association and linkage analysis of α-adducin polymorphism: is the glass half full or half empty? (2000) (51)
Blood pressure in relation to three candidate genes in a Chinese population (2004) (50)
Cardiovascular Risk in Relation to α-Adducin Gly460Trp Polymorphism and Systolic Pressure: A Prospective Population Study (2005) (50)
17β-(3-Furyl)-5β-androstane-3β,14β,17α-triol (PST 2238). A Very Potent Antihypertensive Agent with a Novel Mechanism of Action (1997) (49)
Erythrocyte membrane and renal function in relation to hypertension in rats of the Milan hypertensive strain (1982) (49)
Relationships among endogenous ouabain, α-adducin polymorphisms and renal sodium handling in primary hypertension (2008) (49)
Preoperative Endogenous Ouabain Predicts Acute Kidney Injury in Cardiac Surgery Patients* (2013) (49)
Sodium and glucose transport across renal brush border membranes of Milan hypertensive rats. (1986) (48)
Genetic Mapping of Blood Pressure Quantitative Trait Loci in Milan Hypertensive Rats (2000) (48)
INHIBITION OF GASTROINTESTINAL TRANSIT AND ANTINOCICEPTIVE EFFECTS OF MORPHINE AND FK 33-824 IN RATS ARE DIFFERENTLY PREVENTED BY NALOXONE AND BY ITS N-METHYL QUATERNARY ANALOG (1981) (47)
Na+/K+/Cl(-)-cotransporter mediated Rb+ fluxes in membrane vesicles from kidneys of normotensive and hypertensive rats. (1990) (47)
Reduced platelet glutamate uptake in Parkinson's disease (1999) (47)
Genetic Variation in CYP11B2 and AT1R Influences Heart Rate Variability Conditional on Sodium Excretion (2004) (46)
Altered expression of renal apical plasma membrane Na+ transporters in the early phase of genetic hypertension. (2005) (45)
Abnormal red-cell calcium pump in patients with idiopathic hypercalciuria. (1988) (45)
Alpha-adducin polymorphism in hypertensives of South African ancestry. (2000) (44)
Relationship between altered Na+--K+ cotransport and Na+--Li+ countertransport in the erythrocytes of 'essential' hypertensive patients. (1981) (44)
Upregulation of apical sodium-chloride cotransporter and basolateral chloride channels is responsible for the maintenance of salt-sensitive hypertension. (2008) (43)
Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain. (2009) (43)
Adducin in essential hypertension (1998) (42)
Calcium ATPase in erythrocytes of spontaneously hypertensive rats of the Milan strain. (1985) (42)
Main results of the Ouabain and Adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin (2011) (41)
Relationship between erythrocyte volume and sodium transport in the Milan hypertensive rat and age-dependent changes. (1987) (40)
Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism. (1998) (40)
Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. (2002) (40)
Changes of plasma renin concentration during pressor infusions of renin in the conscious dog: the influence of dietary sodium intake. (1968) (40)
Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain. (1991) (38)
Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. (2002) (38)
Gly460Trp &agr;-Adducin Mutation as a Possible Mechanism Leading to Endolymphatic Hydrops in Ménière's Syndrome (2008) (38)
Tubuloglomerular feedback in hypertensive rats of the Milan strain. (1985) (37)
Endogenous ouabain and the renin–angiotensin–aldosterone system: distinct effects on Na handling and blood pressure in human hypertension (2011) (37)
High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals (2005) (36)
Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats. (1979) (36)
Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm. (2006) (35)
Polymorphism of gamma-adducin gene in genetic hypertension and mapping of the gene to rat chromosome 1q55. (1997) (35)
Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine. (1982) (35)
Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rats. (2004) (35)
A genetic deficiency in calpastatin and isovalerylcarnitine treatment is associated with enhanced hippocampal long‐term potentiation (1995) (34)
Decreased level of calpain inhibitor activity in red blood cells from Milan hypertensive rats. (1986) (34)
Adducin and hypertension. (2005) (34)
Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake (2003) (34)
Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension. (1998) (33)
Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension. (2006) (33)
Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin, Part 1: Experimental Studies (2010) (33)
Disposition of apomorphine in rat brain areas: relationship to stereotypy. (1986) (32)
Epistatic interaction between α- and γ-adducin influences peripheral and central pulse pressures in white Europeans (2004) (32)
Renal function of isolated perfused kidneys from hypertensive (MHS) and normotensive (MNS) rats of the Milan strain at different ages. (1984) (32)
Determination of apomorphine in rat plasma and brain by high-performance liquid chromatography with electrochemical detection. (1985) (31)
Association and linkage analysis of alpha-adducin polymorphism: is the glass half full or half empty? (2000) (31)
Genetics of Essential Hypertension From the Unimodal‐Bimodal Controversy to Molecular Technology (1988) (30)
Characterization of voltage-dependent calcium influx in human erythrocytes by fura-2. (1997) (30)
Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney disease. (1990) (30)
Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human α-adducin (2009) (30)
Stroke volume and left heart anatomy in relation to plasma volume in essential hypertension. (1991) (30)
Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. (2006) (29)
Urinary Kallikrein Excretion in a Spontaneously Hypertensive Strain of Rats (1975) (29)
NKCC2 is activated in Milan hypertensive rats contributing to the maintenance of salt-sensitive hypertension (2011) (28)
Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. (1999) (28)
Role of the kidney in 'salt and water dependent hypertension' of end-stage disease. (1972) (28)
Cardiac and renal hyperplasia in newborn genetically hypertensive rats. (1986) (26)
Renal function of isolated perfused kidneys from hypertensive (MHS) and normotensive (MNS) rats of the Milan strain: role of calcium. (1987) (26)
Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis. (2000) (26)
Influence of familial hypertension of the donor on the blood pressure and antihypertensive therapy of kidney graft recipients. (1982) (26)
A primer on the genetics of hypertension. (1998) (26)
Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. (2007) (26)
Genetics of renal damage in primary hypertension. (1993) (26)
Study of calcium metabolism in idiopathic hypercalciuria by strontium oral load test. (1999) (26)
Erythrocyte Deficiency in Calpain Inhibitor Activity in Essential Hypertension (1988) (25)
Genetics of Hypertension: The Adducin Paradigm (2003) (25)
Genetics of primary hypertension: the clinical impact of adducin polymorphisms. (2010) (25)
Arachidonic acid increases intracellular calcium in erythrocytes. (2002) (24)
High plasma ionized calcium with normal PTH and total calcium levels in normal-function kidney transplant recipients. (1986) (24)
Sodium transport kinetics in erythrocytes and inside-out vesicles from Milan rats. (1991) (24)
Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections. (1998) (24)
Evidence of defective tubuloglomerular feedback control in rats of the Milan hypertensive strain (MHS). (1984) (24)
Personalized Therapy of Hypertension: the Past and the Future (2016) (24)
Association of peripheral and central arterial wave reflections with the CYP11B2 –344C allele and sodium excretion (2004) (23)
The role of the kidney in the rat with genetic hypertension. (1977) (23)
Blood pressure phenotypes in relation to the &bgr;-adducin C1797T polymorphism in the European Project on Genes in Hypertension (EPOGH) (2003) (23)
Ouabain antagonists as antihypertensive agents. (2005) (22)
Effects of Intravenous Endothelin on Hemodynamics and Cardiac Contractility in Conscious Milan Normotensive Rats (1991) (22)
Na+/K+/Cl- cotransport in resealed ghosts from erythrocytes of the Milan hypertensive rats. (1992) (22)
Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog. (1982) (22)
The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications. (2005) (21)
A renal abnormality in the Milan hypertensive strain of rats and in humans predisposed to essential hypertension. (1986) (21)
Genetics of renal mechanisms of primary hypertension: the role of adducin (1997) (21)
Mechanisms involved in renal hypertension. (1975) (21)
Expression analysis of the human adducin gene family and evidence of ADD2 beta4 multiple splicing variants. (2003) (20)
Antihypertensive Compounds That Modulate the Na‐K Pump (2003) (20)
Renal hemodynamics in human subjects and in animals with genetic hypertension during the prehypertensive stage. (1983) (20)
Association of peripheral and central arterial wave reflections with the CYP11B2 -344C allele and sodium excretion (2004) (20)
Characterization of the defective calpain-endogenous calpain inhibitor system in erythrocytes from Milan hypertensive rats. (1986) (20)
Altered expression of renal aquaporins and α-adducin polymorphisms may contribute to the establishment of salt-sensitive hypertension. (2011) (20)
Salt, endogenous ouabain and blood pressure interactions in the general population. (2003) (19)
Glomerular number and size in Milan hypertensive and normotensive rats: their relationship to susceptibility and resistance to hypertension and renal disease (2004) (19)
OASIS-HT: design of a pharmacogenomic dose-finding study. (2005) (19)
Genomic organisation and chromosomal localisation of the gene encoding human beta adducin. (1995) (19)
Renal mechanisms of genetic hypertension: from the molecular level to the intact organism. (1996) (19)
A possible primary role for the kidney in essential hypertension. (1989) (19)
Decreased level of calpain inhibitor activity in kidney from Milan hypertensive rats. (1987) (18)
The value of plasma renin concentration per se, and in relation to plasma and extracellular fluid volume in diagnosis and prognosis of human renovascular hypertension. (1970) (18)
Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin. (1990) (18)
Erythrocyte voltage-dependent calcium influx is reduced in hemodialyzed patients. (1999) (18)
Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future. (2003) (18)
Comparison of various genetic hypertensive rat strains. (1986) (18)
Functional and metabolic effects of propionyl-L-carnitine in the isolated perfused hypertrophied rat heart (1992) (17)
α- and β-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy (2009) (17)
Effect of anticonvulsant drugs on peripheral benzodiazepine receptors of human lymphocytes (1995) (17)
PST 2238: A New Antihypertensive Compound That Modulates Renal Na-K Pump Function Without Diuretic Activity in Milan Hypertensive Rats (2002) (17)
Erythrocyte Na +,K +,CI- cotransport and kidney function in essential hypertension (1993) (17)
Genetic mechanisms underlying the regulation of urinary sodium excretion and arterial blood pressure: the role of adducin. (2000) (17)
Effects of genetic variation in adducin on left ventricular diastolic function as assessed by tissue Doppler imaging in a Flemish population (2008) (16)
Heritability estimate of erythrocyte Na-K-Cl cotransport in normotensive and hypertensive families. (1991) (16)
Genomic Organization of the Human ? Adducin Gene (1999) (16)
Genetic and experimental hypertension in the animal model-similarities and dissimilarities to the development of human hypertension. (1986) (16)
Relations between hypertension and glomerulosclerosis in first-generation hybrid rats of the Milan strains. (1991) (16)
Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels (1984) (16)
Left ventricular geometry and endogenous ouabain in a Flemish population (2009) (16)
Characterisation and chromosomal localisation of the rat α- and β-adducin-encoding genes (1995) (16)
Genetic analysis of blood pressure in the Milan hypertensive strain of rat (Rattus norvegicus). (1986) (16)
PST 2238: A New Antihypertensive Compound that Modulates Na+,K+‐ATPase and Antagonizes the Pressor Effect of OLF (2006) (15)
Alterations in Energy Metabolism of Hypertrophied Rat Cardiomyocytes: Influence of Propionyl‐L-Carnitine (1995) (15)
Expression at the haemopoietic stem cell level of the genetically determined erythrocyte membrane defects in the Milan hypertensive rat strain (MHS). (1983) (15)
Genetic Mapping and Tailored Antihypertensive Therapy (2000) (15)
Familial hypertension and hormonal profile, renal haemodynamics and body fluids of young normotensive subjects. (1978) (14)
Rostafuroxin Protects from Podocyte Injury and Proteinuria Induced by Adducin Genetic Variants and Ouabain (2014) (14)
Erythrocyte calcium influx is related to severity of ventricular arrhythmias in uraemic patients. (2001) (14)
LOCAL AND CNS-MEDIATED EFFECTS OF MORPHINE AND NARCOTIC ANTAGONISTS ON GASTROINTESTINAL PROPULSION IN RATS (1980) (14)
Sodium and potassium concentrations of renal cortical cells two animal models of primary arterial hypertension. (1983) (14)
Differences in ouabain-induced natriuresis between isolated kidneys of Milan hypertensive and normotensive rats. (1992) (13)
Context-dependency of the relation between left ventricular mass and AGT gene variants (2004) (13)
Arterial properties in relation to genetic variations in the adducin subunits in a white population. (2008) (13)
Renal function in essential hypertension (1983) (13)
Cytochemically assayable Na+,K+-ATPase inhibition by Milan hypertensive rat plasma. (1987) (13)
A genetic approach to the pathogenesis of primary hypertension and to its treatment. (1995) (13)
Effect of calcium-activated neutral proteinase (calpain) on rat erythrocyte plasma membrane calcium pump (1995) (12)
Genetic analysis of the SA and Na+/K+‐ATPase α1 genes in the Milan hypertensive rat (1998) (12)
The Milan hypertensive rat as a model for studying cation transport abnormality in genetic hypertension. (1987) (12)
Diuretic effect of bumetanide in isolated perfused kidneys of Milan hypertensive rats. (1990) (12)
Intracellular Electrolyte Composition in Various Experimental Models of Hypertension: an Electron Microprobe Study (1984) (12)
Mechanisms of cyclosporine-induced hypertension. (1991) (12)
Selective modification of renal alpha 2-adrenergic receptors in Milan hypertensive rat strain. (1987) (12)
Plasma concentrations of catecholamines in two strains of spontaneously hypertensive rats at different ages. (1981) (12)
α‐ADDUCIN MAY CONTROL BLOOD PRESSURE BOTH IN RATS AND HUMANS (1995) (12)
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy (2021) (12)
Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension. (2006) (12)
Low-salt diet and diuretic effect on blood pressure and organ damage. (2004) (11)
Characteristics of a ouabain-like factor from Milan hypertensive rats. (1993) (11)
Volumes and Na Transports in Intact Red Blood Cells, Resealed Ghosts, and Inside‐Out Vesicles of Milan Hypertensive Rats (1986) (11)
Cardiovascular control in the Milan strain of spontaneously hypertensive rat (MHS) at "rest" and during acute mental "stress". (1977) (11)
Association of echocardiographic left ventricular structure with the ACE D/I polymorphism: a meta-analysis (2011) (10)
Genomic organization of the human gamma adducin gene. (1999) (10)
Age‐dependency and dietary influence on the hypothalamic ouabain‐like factor in Milan hypertensive rats (1995) (10)
Role of rat alpha adducin in angiogenesis: null effect of the F316Y polymorphism. (2007) (10)
Role of rat α adducin in angiogenesis: Null effect of the F316Y polymorphism (2007) (10)
Registration of trials and protocols (2003) (10)
Antihypertensive effect of captopril, canrenoate potassium, and atenolol. Relations with red blood cell sodium transport and renin. (1988) (10)
Characterization of erythrocyte adducin from the Milan hypertensive strain of rats (1988) (10)
The kidney in the pathogenesis of hypertension. (1991) (10)
Adducin, renal intermediate phenotypes, and hypertension. (2004) (9)
Genetic factors involved in ion transport abnormalities in essential hypertension (1987) (9)
Antigenic Properties of Erythrocyte Membrane from a Hypertensive Strain of Rats (1987) (9)
Relative ability of N-methyl nalorphine and N-methyl levallorphan to prevent antinociception and intestinal transit inhibition in morphine treated rats. (1983) (9)
Heritability of Sodium Transport Systems and Hypertension a (1986) (9)
The Genomics of Cardiovascular Disorders (2000) (9)
Renal lithium clearance in the different stages of hypertension. (1991) (9)
Erythrocytic calpain-calpastatin system in Alzheimer’s disease (1996) (9)
Glucocorticoid receptor polymorphism in genetic hypertension. (1998) (9)
cGMP-Dependent Protein Kinase 1 Polymorphisms Underlie Renal Sodium Handling Impairment (2013) (9)
(Ca+Mg)ATPase and calcium influx in erythrocytes of patients with idiopathic hypercalciuria. (1995) (9)
Effect of canrenone and hydrochlorothiazide on the development of hypertension in rat models of genetic hypertension (1993) (9)
Listeria rhombencephalitis: report of two cases with early diagnosis and favourable outcome (1995) (8)
alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy. (2010) (8)
Erythrocyte membrane transport systems as possible markers for essential hypertension (1982) (8)
Why is [Ca2+]i increased in blood cells in primary hypertension? (1985) (8)
Renal genetic mechanisms of essential hypertension. (1997) (7)
Effect of propionyl-L-carnitine on the mechanics of right and left papillary muscles from volume-overloaded rat hearts. (1996) (7)
The calpain-calpastatin system in obsessive-compulsive disorder (1997) (7)
Blood pressure in patients with four different primary glomerulopathies. (1984) (7)
Renal Abnormalities at the Prehypertensive Stage of Essential Hypertension (1988) (7)
The genomics of cardiovascular disorders: therapeutic implications. (2000) (7)
Simultaneous determination of buspirone, gepirone, ipsapirone and their common metabolite 1-(2-pyrimidinyl)piperazine in rat plasma and brain by high-performance liquid chromatography. (1988) (7)
Genetic determinants and renal mechanisms in essential hypertension. (1996) (6)
PST 2238 a new antihypertensive compound that modulates renal Na-KATPase in genetic hypertension. (1999) (6)
Are retinal microvascular phenotypes associated with the 1675G/A polymorphism in the angiotensin II type-2 receptor gene? (2011) (6)
Renal function in relation to three candidate genes in a Chinese population (2004) (6)
The alpha-adducin polymorphism: a paradigm to analyse the genetics of primary hypertension. (1995) (6)
Left Ventricular Radial Function Associated With Genetic Variation in the cGMP-Dependent Protein Kinase (2013) (6)
Clinical impact of adducin polymorphism. (2009) (6)
Cation Transport Abnormalities in Human and Rat Essential Hypertension (1984) (6)
Ouabain and serum sodium. (2005) (6)
Effect of amiloride analogues on sodium transport in renal brush border membrane vesicles from Milan hypertensive rats. (1992) (6)
Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan (2020) (6)
Effects of captopril and of other antihypertensive drugs on cell membrane ion transport--a preliminary report. (1986) (6)
Increase in plasma extracellular fluid volume ratio caused by bilateral nephrectomy in patients on maintenance hemodialysis. (1978) (6)
Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure. (2007) (6)
Haplotype analysis of carnitine transporters and left ventricular mass in human essential hypertension. (2005) (6)
Chloride fluxes activated by parathyroid hormone in human erythrocytes. (2000) (6)
Pathogenetic mechanisms in essential hypertension. Analogies between a rat model and the human disease. (1989) (6)
Calcium transport in basolateral plasma membranes from kidney cortex of Milan hypertensive rats. (1988) (5)
Role of cellular sodium and calcium metabolism in the pathogenesis of essential hypertension. (1988) (5)
Renal Haemodynamics are not Related to Genotypes in Offspring of Parents with Essential Hypertension (2006) (5)
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function (2021) (5)
17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action. (1997) (5)
Renal Mechanisms and Calcium in the Pathogenesis of a Type of Genetic Hypertension (1986) (5)
Characterisation and chromosomal localisation of the rat alpha- and beta-adducin-encoding genes. (1995) (5)
Cell membrane abnormalities and genetic hypertension. (1986) (5)
Nonacidotic kidney proximal tubulopathy with absorptive hypercalciuria. (1995) (5)
Renal Mechanisms in the Pathogenesis of Essential Hypertension (1981) (5)
The kidney in essential hypertension. (1985) (5)
Antidiuretic effect of bremazocine and U‐50,488 in rats after α2‐adrenoceptor blockade (1991) (4)
Effect of propionyl-L-carnitine on rats with experimentally induced cardiomyopathies (1995) (4)
Genetic aspects of ion transport systems in hypertension. (1990) (4)
Mechanism of the antihypertensive effect of FCE 22716, a new ergoline derivative, in the spontaneously hypertensive rat. (1989) (4)
Haematological phenotypes in relation to the C1797T beta-adducin polymorphism in a Caucasian population. (2003) (4)
Nonacidotic proximal tubulopathy transmitted as autosomal dominant trait. (1997) (4)
Ion transport across blood cell membrane in essential hypertension (1986) (4)
The 460Trp allele of ADD1 activates ROS production and causes endothelial dysfunction in essential hypertension (2005) (4)
The peripheral narcotic antagonist N‐allyl levallorphan‐bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in‐vivo binding in the rat intestine (1984) (4)
Modifications of diazepam binding inhibitor and peripheral benzodiazepine receptors in the lymphocytes of epileptic patients (1996) (4)
Genetic Hypertension and the Kidney (1984) (4)
A clinical double-blind study of flumazenil, antagonist of benzodiazepines, in loco-regional anesthesia. (1992) (4)
Membrane abnormalities in essential hypertension: physiologic and genetic links. (1986) (4)
Na+,K+,Cl‐ cotransport is a marker of distal tubular function in essential hypertension (1995) (3)
Effect of propionyl-L-carnitine treatment on mechanical properties of papillary muscles from pressure-overload hypertrophied rat hearts (1992) (3)
Left ventricular structure and function in relation to steroid biosynthesis genes in a white population. (2012) (3)
Acute tubular necrosis and arterial hypertension in renal transplant patients treated with ciclosporin. (1986) (3)
Istaroxime improves diabetic diastolic dysfunction through SERCA stimulation (2019) (3)
PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'. (2000) (3)
49. The hypothalamic ouabain-like factor in the Milan hypertensive rats (1991) (3)
Na+, kidney, hypertension and genes: lessons from rats. (2004) (3)
Calpastatin level in spontaneously hypertensive rats. (1991) (3)
Tissue-specific modulation of β-adducin transcripts in Milan hypertensive rats (2003) (3)
Erythrocyte calpain activity and left ventricular mass in essential hypertension (1997) (3)
The Kidney in Essential Hypertension1 (1985) (3)
Transcapillary protein escape in arterial hypertension (1980) (3)
Pathophysiology of hypertension. (1997) (3)
Erythrocyte membrane calcium transport in patients with primary hyperparathyroidism. (1994) (3)
High-performance liquid chromatographic assay of k-opioid selective benzeneacetamide derivatives (U50488, U69593 and PD117302) in rat plasma and brain. (1989) (3)
Genetic models of arterial hypertension — role of tubular ion transport (1993) (2)
Pathophysiology of hypertension. (1997) (2)
Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension (2006) (2)
Are the new single nucleotide polymorphisms (SNPs) relevant for hypertensive populations? (2002) (2)
Limits for use of heparin in ionized calcium determination (1984) (2)
A new rat model for studying the calpain-calpastatin system (1995) (2)
Association between blood pressure, hypertension and polymorphisms of the aldosterone synthase and ?-adducin genes in a Belgian population study (2000) (2)
Ca-ATPase in erythrocyte membrane ghost cells of MHS rats. (1986) (2)
Stability of charge-pump phase-locked loops: the hold-in and pull-in ranges (2020) (2)
, implications for tubular Na reabsorption renal cells by affecting constitutive endocytosis :-Adducin mutations increase Na / K pump activity in (2008) (2)
Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words (typed, double-spaced) in length and may be subject to editing or abridgment. (2005) (2)
Relationships among alterations in renal membrane sodium transport, renin and aminopeptidase M activities in genetic hypertension. (1993) (2)
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure (2022) (2)
Ouabain and Adducin for Specific Intervention on Sodium in HyperTension ( OASIS-HT ) : design of a pharmacogenomic dose-finding study (2004) (2)
Hypertension related adducin polymorphism affects Na-KATPase activity (1997) (2)
Pharmacogenomics and genetics of primary hypertension (2001) (2)
Changes in cell membrane transport and kidney function in relation to 'essential' hypertension. (1982) (2)
Sodium balance and peripheral resistance in arterial hypertension. (1984) (2)
Membrane Abnormalities in Essential Hypertension: (1986) (1)
Kinetics and brain uptake of S 9795, a new xanthine derivate, in rats (1989) (1)
Abnormal regulation of calcium transport in renal basolateral plasma membranes of Milan hypertensive rats. (1988) (1)
Antihypertensive ergolinepropionamides. (1983) (1)
A New Selective Antagonist of Vascular Serotonin Receptors Lowers Blood Pressure in Spontaneously Hypertensive Rats (2012) (1)
Ion Transport and the Cytoskeleton in Hypertension: a genetic link (1995) (1)
34 The role of membrane skeleton in the alteration of Na‐K cotransport in Milan hypertensive rats (1988) (1)
Abstracts of learning resource centre (1994) (1)
Ouabain-Like (OLF) and Na-K Pump in Genetic Hypertension of Rats and Humans (1997) (1)
Contribution of genetic polymorphism of ACE and alpha-adducin to salt sensitivity of hypertension. (1997) (1)
Glucocorticoid receptor mutations in genetically hypertensive rats: markers of glucocorticoid insensitivity? (1997) (1)
OR-9: A-adducin Gly 460Trp polymorphism and the cardiovascular risk associated with systolic pressure — a prospective population study (2005) (1)
Evidence‐based medicine: EDITORIAL COMMENT (1998) (1)
A Primary Kidney Abnormality in Essential Hypertension1 (1987) (1)
Relationship between red blood cell function, kidney function and blood pressure in genetic hypertension. (1985) (1)
Intra-erythrocyte cation concentrations in relation to the C1797T β-adducin polymorphism in a general population (2007) (1)
Involvement of peripheral dopamine receptors in the antihypertensive effect of a new ergoline derivative (355/1057). (1985) (1)
Genetic polymorphism of Na-K cotransport in essential hypertension. (1990) (1)
Influence of ACE and alpha-adducin (ADDI) polymorphisms on ACE activity in cultured human skin fibroblasts (2002) (1)
On a test for rapid cryoglobulin detection (1980) (1)
A primary kidney abnormality in essential hypertension. (1987) (1)
P-275: Singular and epistatic effects of three candidate genes on carotid and femoral intima-media thickness in a Caucasian population (2001) (1)
Increased Circulating Na+-K+-Atpase Inhibitor in the Young and Adult Milan Hypertensive Strain Rat (1986) (1)
Different effects of PTH on erythrocyte calcium influx (1996) (1)
Ion Transport Abnormalities in the Development of Hypertension (1991) (1)
Effect of propionyl-l-carnitine and enalapril on cardiac function of pressure-overloaded rats during increase in load. (1995) (1)
UP-REGULATION OF APICAL SODIUM CHLORIDE COTRANSPORTER AND BASOLATERAL CHLORIDE CHANNELS ARE RESPONSIBLE FOR THE MAINTENANCE OF SALT SENSITIVE HYPERTENSION (2008) (1)
Cardiovascular effects of a new antihypertensive agent in several species. (1983) (1)
[Cellular metabolism of sodium and hypertension]. (1989) (0)
polymorphism to clinical symptoms leading to ''primary'' hypertension: from gene Genetic variations of tubular sodium reabsorption (2016) (0)
The role of adducin in hypertension (1998) (0)
19 Two point mutations within the adducin genes are responsible for variation in blood pressure, kidney and erythrocyte size: a new mechanism for genetic hypertension (1993) (0)
Genetic diseases and molecular genetics - 2 (2011) (0)
Autonomic nervous modulation, renin-angiotensin-aldosterone system genus and salt intake in white europeans (2003) (0)
P-165: Renal function in relation to three candidate genes in a caucasian population (2001) (0)
Book Review Secondary Hypertension: Clinical Presentation, Diagnosis, and Treatment (Clinical Hypertension and Vascular Diseases.) Edited by George A. Mansoor. 352 pp., illustrated. Totowa, N.J., Humana Press, 2004. $99.50. 1-58829-141-3 (2004) (0)
98. Relevance of renin and erythrocyte sodium transport on the antihypertensive effect of K-canrenoate and hydrochlorothiazide (1991) (0)
Interaction between NEDD4L and alfa-adducin polymorphisms on blood pressure (2005) (0)
In vitro binding profile and in vivo pharmacological properties of the K-opioid compound PD 117302. (1991) (0)
Hydroxyamino and hydrazino-14beta-hydroxyandrostanderivater with activity on the cardiovascular system, to processes for their preparation and pharmaceutical compositions containing them. (1995) (0)
maintenance of salt-sensitive hypertension the and basolateral chloride channels is responsible for Upregulation of apical sodium-chloride cotransporter (2011) (0)
A Correction to the Research Article Titled: "Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin. Part 1: Experimental Studies" by Mara Ferrandi, Isabella Molinari, Lucia Torielli, Gloria Padoani, Sergio Salardi, Maria Pia Rastaldi, Patrizia Ferrari, Giu (2010) (0)
Active and inactive renin and kidney function in young subjects with different predisposition to develop essential hypertension. (1982) (0)
[Various pathogenetic aspects of renal arterial hypertension]. (1970) (0)
New cardioactive 17-Iminomethylalkenyl-5-beta-14-beta-androstan and 17-iminoalkyl-5-beta, 14-beta-androstane derivatives, to a process for their preparation and pharmaceutical compositions thereof (1994) (0)
PERIPHERAL SELECTIVITY OF QUATERNARY NARCOTIC ANTAGONISTS:RELATIVE ABILITY TO PREVENT GASTROINTESTINAL TRANSIT INHIBITION AND ANTINOCICEPTION IN MORPHINIZED RATS.a) (1981) (0)
Altered urinary kallikrein in spontaneously hypertensive rats, selectively bred (1975) (0)
A new selective antagonist of the ouabain pressor effect (1995) (0)
Antidiuretic effect of bremazocine and U-50,488 in rats after alpha 2-adrenoceptor blockade. (1991) (0)
Listeria rhombencephalitis" cases with early diagnosis and favourable outcome (1995) (0)
BLOOD PRESSURE VARIES WITH PHYSIOLOGICALLY DETERMINED EPIGENETIC INTERACTIONS AMONG THE ADDUCIN GENES IN 6 EUROPEAN POPULATIONS: PE.10 (2005) (0)
GENES INVOLVED IN THE BIOSYNTHETIC PATHWAY OF ENDOGENOUS QUABAIN IN HUMAN HYPERTENSION: P 769 (2004) (0)
POST-MENOPAUSAL HYPERTENSIVE EFFECTS OF ALPHA-ADDUCIN: P 654 (2004) (0)
Peripheral benzodiazepine receptors and diazepam binding inhibitor in lymphocytes of demented patients (1996) (0)
PLATELETS AS PERIPHERAL MODEL OF GLUTAMATE-RELATED EXCITOTOXICITY IN PARKINSON'S DISEASE (1996) (0)
ALPHA 2 renal adrenoreceptors in young hypertensive rats (Milano strain) (1985) (0)
transporters in the early phase of genetic hypertension + Altered expression of renal apical plasma membrane Na (2016) (0)
Genetic Abnormalities of the Na-K-Cl Cotransport in Experimental and Primary Hypertension (2019) (0)
PERIPHERAL BENZODIAZEPINE RECEPTORS INCREASE IN LYMPHOCYTES OF DIABETIC PATIENTS (1992) (0)
Polymorphisms in the a-L-Iduronidase gene is associated with progression rate in IGA nephropathy (2005) (0)
PHERIPHERAL BENZODIAZEPINE RECEPTORS IN LYMPHOCYTES OF ESSENTIAL HYPERTENSIVE PATIENTS (1995) (0)
A Genetically Determined Link (2005) (0)
TRANSFER OF α-ADDUCIN GENE FROM MILAN HYPENTENSIVE INTO MILAN NORMOTENSIVE RATS RISES BLOOD PRESSURE AND RENAL NaK PUMP ACTIVITY: P2.109 (2000) (0)
LONGITUDINAL CHANGE IN BLOOD PRESSURE IN RELATION TO 5 CANDIDATE GENES AND URINARY SODIUM EXCRETION IN 1405 SUBJECTS FROM 5 EUROPEAN POPULATIONS: 9D.01 (2011) (0)
THE CARDIOVASCULAR EFFECTS OF SUB-NANOMOLAR OUABAIN CONCENTRATIONS DEPEND ON THE SIGNAL-TRANSDUCTION ACTIVATION WITHIN CAVEOLAE AND ARE ANTAGONIZED BY PST 2238: 1C.6 (2004) (0)
Can angiotensin II cause renal hypertension when its plasma concentration is normal? (1977) (0)
Effect of L-carnitine (LC) on oxidative metabolism in isolated cardiac myocytes from normal and hypertrophic rat heart (1992) (0)
163. Characteristics of sodium???potassium-chloride cotransport in resealed ghosts in the Milan rat strain (1991) (0)
Abstract 3479: RFX1 Transcription Factor Differentially Interacts with Adducin Gly460Trp Variants to Regulate Alpha 1 Na,K-ATPase Gene (ATP1A1) Expression (2008) (0)
Relation between ambulatory blood pressure and b-adducin polymorphism in European populations (2002) (0)
[Is essential hypertension sustained by a primary intrarenal defect?]. (1979) (0)
[Separate kidney function in diagnosis of monolateral nephropathies. Studies of 47 cases]. (1971) (0)
The genetics of essential hypertension (1989) (0)
Left Ventricular Mass in Relation to Genetic Variation in Angiotensin II Receptors, Renin System Genes, and Sodium Excretion Molecular Cardiology (2004) (0)
P-284: Combined effects on vascular wall characteristics of the ACE I/D polymorphism and mutations of the A-B-Γ adducin genes (2001) (0)
Epigenetic interaction between α-adducin and renin-angiotensin-system genes in relation to the elastic properties of the femoral artery (2007) (0)
Propionyl-L-carnitine (PLC) improves cardiac function in rats with pressure overload cardiac hypertrophy (1995) (0)
Azaheterocyclyl androstane derivatives and androstenes as drugs for cardiovascular disorders (2007) (0)
[Physiologic role of the sodium pump. Implications for the study of arterial hypertension]. (1989) (0)
213 Molecular cloning of alpha- and beta-adducin protein in normotensive and hypertensive rats of the Milan strain (1993) (0)
Ion Transport in Red Blood Cells and Antihypertensive Therapy (1986) (0)
Moderate hyposodic diet: Effect of alpha-adducin, ACE genes and endogenous ouabain on blood pressure fall (2005) (0)
ASSOCIATION OF ECHOCARDIOGRAPHIC LEFT VENTRICULAR STRUCTURE WITH THE ACE D/I POLYMORPHISM: A META-ANALYSIS: PP.22.364 (2010) (0)
Renal function in primary hypertension (1992) (0)
Renal Transplantation, Blood Pressure, and Hypertension (1992) (0)
P-218 MP-5: Role of ANP gene on cardiac hypertrophy in essential hypertension (2005) (0)
Selective Modification of Renal ayAdrenergic Receptors in Milan Hypertensive Rat Strain (2005) (0)
5 BETA 14 BETA-androstane FOR USE FOR THE TREATMENT OF DISEASES CAUSED BY ORGAN FIBROSIS (2008) (0)
ALPHA-ADDUCIN AND ANGIOTENSIN CONVERTING ENZYME POLYMORPHISMS: INFLUENCES ON THE PRESSURE-NATRIURESIS RELATIONSHIP IN HYPERTENSIVES (2004) (0)
1,5 disubstituted derivatives 7a-3a-ol-metilperhidroinden, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them. (1995) (0)
Plenary session I: awards session : Genetics and pharmacogenomics of renal mechanisms of hypertension (1999) (0)
Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome Polymorphisms : FromGly 460 Trp-Adducin α and I / DAngiotensin-Converting Enzyme (2007) (0)
LEFT VENTRICULAR SYSTOLIC FUNCTION IN RELATION TO GENETIC VARIATION IN THE CYCLIC GMP-DEPENDENT PROTEIN KINASE: 6B.04 (2010) (0)
P-342: Blood pressure and polymorphisms of α-and β-adducin genes in a white population (2002) (0)
[Plasmatic concentration of renin in human arterial hypertension]. (1966) (0)
Tissue-specific modulation of beta-adducin transcripts in Milan hypertensive rats. (2003) (0)
RENAL FUNCTION IN RELATION TO THREE CANDIDATE GENES IN A CHINESE POPULATION: P 112 (2004) (0)
Circulating Natriuretic Factor in the Pathogenesis of Genetic Hypertension of Renal Origin (1987) (0)
Inotropic properties of a novel Na, K-ATPase inhibitor, PST 2107 (1999) (0)
Hypertension-Linked Mutation in the Adducin (cid:1) -Subunit Leads to Higher AP2- (cid:2) 2 Phosphorylation and Impaired Na -ATPase Trafficking in Response to GPCR Signals and Intracellular Sodium (2004) (0)
Spontaneous Hypertension, Morphologic Aspects, Rat (1986) (0)
[LB.02.08] ADDUCIN AND OUABAIN-RELATED GENETIC POLYMORPHISMS ARE ASSOCIATED WITH HYPERTENSION AND CORONARY ARTERY DISEASE IN A TAIWANESE POPULATION (2017) (0)
Istaroxime stimulates SERCA 2 a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition 1 Running title : Istaroxime stimulation of SERCA 2 a in heart failure (2013) (0)
EFFECT OF A LANOSTEROL SYNTHASE POLYMORPHISM AFFECTING BLOOD PRESSURE AND ENDOGENOUS OUABAIN BIOSYNTHESIS IN TWO DIFFERENT CLINICAL SETTINGS: 4A.11 (2011) (0)
PROC.18TH WORLD CONGRESS, INT.COLLEGE SURGEONS (1973) (0)
[The role of renal pressure in arterial hypertension of chronic terminal uremia]. (1972) (0)
Essential hypertension (2003) (0)
Evidence-based medicine. (1998) (0)
Role of the Kidney in the Pathogenesis of Primary Hypertension (1982) (0)
[Introduction to the problem of relationship between renin, sodium and hydric spaces in the pathogenesis of renal hypertension]. (1972) (0)
HEART-FAILURE - DISCUSSION (1986) (0)
ALPHA-ADDUCIN TRP ALLELE IS STRONGLY ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN YOUNG ADULT MALES: P2.209 (2004) (0)
Derivatives of amino homoandrostaner-B and B-heteroandrostaner (2007) (0)
New 17-hydroxyimino-5beta, 14beta-androstane derivatives, kardioaktives processes for their preparation and pharmaceutical compositions thereof (1993) (0)
[Changes in cation transport in the erythrocytes of normotensive young persons predisposed to essential hypertension]. (1981) (0)
Acid-base, nephrolithiasis and divalent ions (2009) (0)
[Sodium transport and renal hemodynamics in arterial hypertension of genetic origin: primary or secondary changes?]. (1988) (0)
The Kidney in arterial hypertension : proceedings of a symposium held in Venice, Italy, June 8, 1978 (1979) (0)
P.3.025 The calpain-calpastatin system in obsessive-compulsive disorder (1997) (0)
OUTCOME OF BLOOD PRESSURE AND RENAL FUNCTION AFTER PTRA AND STENTING OF ATHEROSCLEROTIC RENAL ARTERY STENOSIS: P 596 (2004) (0)
Are retinal microvascular phenotypes associated with 1675G/A polymorphism in angiotensin II receptor-2 gene? (2011) (0)
407 Beta-adducin gene polymorphisms influence response to diuretic therapy in patients with heart failure due to idiopathic dilated cardiomyopathy (2007) (0)
ssociation of Atrial Natriuretic eptide and Type A Natriuretic Peptide eceptor Gene Polymorphisms With Left entricular Mass in Human Essential Hypertension (2006) (0)
Endogenous ouabain-like factor predicts progression toward heart failure in patients with idiopathic dilated cardiomyopathy (2002) (0)
[Radionephrogram and minute urography in the diagnosis of monolateral hypertensive nephropathies]. (1969) (0)
ADDUCIN PARADIGM: AN APPROACH TO THE COMPLEXITY OF HYPERTENSION GENETICS (2002) (0)
Hypertension Association Between Aldosterone Synthase ( CYP 11 B 2 ) Polymorphism and Left Ventricular Mass in Human Essential Hypertension (2016) (0)
CARDIOVASCULAR EFFECTS OF CHRONIC LOW-DOSE OUABAIN ADMINISTRATION IN RATS: P2.106 (2004) (0)
New 17- (3-imino-2-alkyl-propenyl) -5beta-14beta-androstane derivatives for the treatment of cardiovascular diseases, a process for their preparation and pharmaceutical compositions thereof (1995) (0)
New 17- (3-imino-2-alkylpropylen) -5ß, 14ss-androstane derivatives, which act on the cardiovascular system, to processes for their preparation and pharmaceutical compositions containing them (1994) (0)
The Isolated Perfused Rat Kidney as a Model for the Study of Diuretics in Hypertension (1987) (0)
EFFECT OF THE HUMAN MUTATED ALPHA-ADDUCIN ON THE NA/K PUMP: P2.223 (2004) (0)
Association between plasma membrane (Ca+Mg) ATPase and calpain/calpastatin system in rat erythrocytes. (1996) (0)
adducin-dependent hypertension - ATPase alterations in ouabain and + -K + and vascular Na Rostafuroxin: an ouabain antagonist that corrects renal (2016) (0)
[Plasmatic concentration of renin and arterial pressure in the waking dog]. (1966) (0)
Alpha-adducin and salt sensitivity (1998) (0)
FOUR HUMAN GENE VARIANTS PREDICT THE ANTIHYPERTENSIVE ACTIVITY OF ROSTAFUROXIN, A SELECTIVE INHIBITOR OF THEIR EFFECTS ON THE NA, K PUMP: PP.21.316 (2010) (0)
Erythrocyte sodium transport systems in Type 1 (insulin-dependent) diabetic nephropathy (1989) (0)
Aquaporin 2 and Adducin Polymorphism Impact on Essential Hypertension (2008) (0)
The amytal and the cold pressor tests in relation to the aetiology and to the therapy of arterial hypertension. (1970) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giuseppe Bianchi?

Giuseppe Bianchi is affiliated with the following schools:

Giuseppe Bianchi's Academic­Influence.com Rankings

Giuseppe Bianchi's Degrees

Similar Degrees You Can Earn

Why Is Giuseppe Bianchi Influential?

Giuseppe Bianchi's Published Works

Published Works

What Schools Are Affiliated With Giuseppe Bianchi?

Giuseppe Bianchi's AcademicInfluence.com Rankings